AAV2-hCHM Subretinal Delivery to the Macula in Choroideremia: 2 year Results of an Ongoing Phase I/II Gene Therapy TrialTomás S. Alemán, Albert M. Maguire, Rachel M. Huckfeldt et al.|Investigative Ophthalmology & Visual Science|2019Cited by 7
Safety of the Subretinal Delivery of RGX-314 AAV8-anti-VEGF Fab Gene Therapy in NHP: Retinal Structure Over One YearMichael J. Ammar, Tomás S. Alemán, Gui‐Shuang Ying et al.|Investigative Ophthalmology & Visual Science|2018Cited by 2
Safety of subretinal delivery of RGX-314 (AAV8-anti-VEGF Fab) in the non-human primate as assessed by full-field ERGArkady Lyubarsky, Jean Bennett, Erik Wielechowski et al.|Investigative Ophthalmology & Visual Science|2018Cited by 1